In recent years, radiotherapy based salvage treatments have undergone significant developments. Salvage brachytherapy had already shown promising results in the whole gland and focal setting in terms of tumour control and toxicity (2)(3). Current focus has shifted towards, MRI-guided radiotherapy delivery with machines able to treat a variety of recurrent lesions. A nice overview of the possibilities is given by the case reports described in the paper of Montalvo et al. (4), where patients with recurrences both after radiotherapy and prostatectomy in several anatomical locations are described. It provides a glimpse of what the future of salvage MRI-guided re-irradiation has in store for us.Although external beam radiotherapy techniques have improved significantly over the last years, the steep dose falloff of brachytherapy carries advantages for surrounding organs at risk. Ménard and colleagues give us an overview on the use of focal salvage high dose rate (HDR) brachytherapy to the recurrent tumour area or as a boost in a whole-gland salvage setting. Although out of field recurrences might be slightly higher when targeting only the recurrent lesions, both approaches were associated with high biochemical (control) rates and no severe toxicity (although grade 2 genitourinary and gastrointestinal toxicity was higher when using a whole gland with boost approach). This led to stable quality of life in the described cohort.Whether a whole-gland or focal approach is warranted is addressed by King et al. in which they provide a method of choosing between the strategies. This risk-adapted paradigm enables clinicians to choose between focal or whole-gland salvage and is a great addition to the set of papers dealing with this issue (5).Brachytherapy is conventionally applied transperineally under ultrasound and more recently under MRI guidance. A new technique using transperirectal application under CT guidance with a personalised 3D-template is described by Di et al. (6). They name several circumstances and potential advantages of this technique.
7 Authors
- WL
Wenqiang Liao
Department of Urology, Second Affiliated Hospital of Shantou University Medical College, China
- XS
Xuxia Sui
Laboratory of Pathogenic Biology, Shantou University Medical College, China
- GH
Gaoming Hou
Department of Urology, Second Affiliated Hospital of Shantou University Medical College, China
- MY
Mei Yang
Department of Urology, Second Affiliated Hospital of Shantou University Medical College, China
- YL
Yuxue Lin
Department of Urology, Second Affiliated Hospital of Shantou University Medical College, China
- JL
Junjie Lu
Department of Clinical Medicine, Shantou University Medical College, China
- QY
Qingtao Yang
Department of Urology, Second Affiliated Hospital of Shantou University Medical College, China
4,206 views
4 citations
9 Authors
- XD
Xuemin Di
Department of Oncology, Hebei General Hospital, China
- HZ
Hongtao Zhang
Department of Oncology, Hebei General Hospital, China
- XL
Xiaoli Liu
Department of Oncology, Hebei General Hospital, China
- JZ
Jinxin Zhao
Department of Oncology, Hebei General Hospital, China
- ZG
Zhen Gao
Department of Oncology, Hebei General Hospital, China
- HY
Huimin Yu
Department of Oncology, Hebei General Hospital, China
- XS
Xiaohua Su
Department of Oncology, Hebei General Hospital, China
- YL
Yansong Liang
Department of Oncology, Hebei General Hospital, China
- JW
Juan Wang
Department of Oncology, Hebei General Hospital, China
3,380 views
6 citations
9 Authors
- MT
Martin T. King
Department of Radiation Oncology, Brigham and Women’s Hospital, United States
- DD
David D. Yang
Department of Radiation Oncology, Brigham and Women’s Hospital, United States
- AV
Anthony V. D’Amico
Department of Radiation Oncology, Brigham and Women’s Hospital, United States
- IB
Ivan Buzurovic
Department of Radiation Oncology, Brigham and Women’s Hospital, United States
- TC
Thomas C. Harris
Department of Radiation Oncology, Brigham and Women’s Hospital, United States
- CV
Christian V. Guthier
Department of Radiation Oncology, Brigham and Women’s Hospital, United States
- GS
Graeme S. Steele
Department of Urology, Brigham and Women’s Hospital, United States
- MN
Martin N. Kathrins
Department of Urology, Brigham and Women’s Hospital, United States
- AD
Atish D. Choudhury
Department of Medical Oncology, Dana-Farber Cancer Institute, United States
2,721 views
4 citations
5 Authors
- QX
Qin Xue
Department of Urology, Xijing Hospital, Fourth Military Medical University, China
- JZ
Jingliang Zhang
Department of Urology, Xijing Hospital, Fourth Military Medical University, China
- JJ
Jianhua Jiao
Department of Urology, Xijing Hospital, Fourth Military Medical University, China
- WQ
Weijun Qin
Department of Urology, Xijing Hospital, Fourth Military Medical University, China
- XY
Xiaojian Yang
Department of Urology, Xijing Hospital, Fourth Military Medical University, China
18 Authors
- CM
Cynthia Ménard
Radiation Oncology, Centre Hospitaliser de l’Université de Montréal (CHUM), Canada
- IN
Inmaculada Navarro-Domenech
Princess Margaret Cancer Centre, University of Toronto, Canada
- Z(
Zhihu (Amy) Liu
Princess Margaret Cancer Centre, University of Toronto, Canada
- LJ
Lisa Joseph
Princess Margaret Cancer Centre, University of Toronto, Canada
- MB
Maroie Barkati
Radiation Oncology, Centre Hospitaliser de l’Université de Montréal (CHUM), Canada
- AB
Alejandro Berlin
Princess Margaret Cancer Centre, University of Toronto, Canada
- GD
Guila Delouya
Radiation Oncology, Centre Hospitaliser de l’Université de Montréal (CHUM), Canada
- DT
Daniel Taussky
Radiation Oncology, Centre Hospitaliser de l’Université de Montréal (CHUM), Canada
- MB
Marie-Claude Beauchemin
Radiation Oncology, Centre Hospitaliser de l’Université de Montréal (CHUM), Canada
- BN
Benedicte Nicolas
Radiation Oncology, Centre Hospitaliser de l’Université de Montréal (CHUM), Canada
- SK
Samuel Kadoury
Radiation Oncology, Polytechnique Montreal, Canada
- AR
Alexandra Rink
Princess Margaret Cancer Centre, University of Toronto, Canada
- SR
Srinivas Raman
Princess Margaret Cancer Centre, University of Toronto, Canada
- AS
Aravindhan Sundaramurthy
Princess Margaret Cancer Centre, University of Toronto, Canada
- RW
Robert Weersink
Princess Margaret Cancer Centre, University of Toronto, Canada
- DB
Dominic Beliveau-Nadeau
Radiation Oncology, Centre Hospitaliser de l’Université de Montréal (CHUM), Canada
- JH
Joelle Helou
Princess Margaret Cancer Centre, University of Toronto, Canada
- PC
Peter Chung
Princess Margaret Cancer Centre, University of Toronto, Canada
3,319 views
20 citations
15 Authors
- MW
Mike Wenzel
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Germany
- CW
Christoph Würnschimmel
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Canada
- LN
Luigi Nocera
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Canada
- CC
Claudia Colla Ruvolo
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Canada
- BH
Benedikt Hoeh
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Germany
- ZT
Zhe Tian
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Canada
- SF
Shahrokh F. Shariat
Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Austria
- FS
Fred Saad
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Canada
- AB
Alberto Briganti
Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Italy
- MG
Markus Graefen
Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Germany
- FP
Felix Preisser
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Germany
- AB
Andreas Becker
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Germany
- PM
Philipp Mandel
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Germany
- FK
Felix K. H. Chun
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Germany
- PI
Pierre I. Karakiewicz
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Canada
2,135 views
6 citations
7 Authors
- SK
Steven K. Montalvo
Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern, United States
- BM
Boyu Meng
Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern, United States
- ML
Mu-Han Lin
Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern, United States
- CP
Chunjoo Park
Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern, United States
- NB
Neil B. Desai
Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern, United States
- RH
Raquibul Hannan
Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern, United States
- AG
Aurelie Garant
Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern, United States
3,560 views
5 citations
